IFGL Refractories consolidated PAT jumps 58% YoY, revenue +13%, on US profit turnaround
PAT +57.8% YoY · revenue +12.9% · margins expanding
₹512.37 Cr
+12.9% YoY
₹17.06 Cr
+57.8% YoY
3.31%
+0.9pp YoY
₹2.37
IFGL Refractories' consolidated (primary) Q1 FY27 (quarter ended June 30, 2026) revenue rose 12.9% YoY to ₹512.4 Cr (₹454.0 Cr in Q1 FY26; +6.1% QoQ from ₹483.0 Cr), while PAT jumped 57.8% YoY to ₹17.06 Cr (₹10.81 Cr a year ago; +19.5% QoQ from ₹14.28 Cr), taking EPS to ₹2.37 from ₹1.50. Neither this quarter nor the year-ago quarter carried exceptional items, so the growth is entirely underlying with no one-off adjustment needed. Standalone (India-only) PAT grew a much softer 7.1% YoY to ₹15.78 Cr on revenue of ₹296.6 Cr — the wide gap versus consolidated confirms the growth is coming almost entirely from overseas operations rather than the domestic book.
Q1 FY-2027 vs prior quarters
Net margin expanded to 3.33% from 2.37% a year ago, helped by a lower effective tax rate (26.3% vs 28.75% in Q1 FY26). But operating profitability actually compressed: EBITDA margin fell to roughly 7.2% from ~7.9% both YoY and QoQ, driven by raw material costs rising to 52.6% of revenue from 47.1% in Q1 FY26 (+5.6pp), partly offset by a lighter trading mix (purchase of stock-in-trade fell to 1.3% of revenue from 5.6%). Segment data shows exactly where the growth came from: America segment profit (before finance costs/tax) more than doubled to ₹10.84 Cr from ₹6.04 Cr (+79.5% YoY) on revenue up 32.4% to ₹102.2 Cr, and Europe's loss narrowed 18% to ₹7.09 Cr from ₹8.69 Cr — both directly matching management's Q4 FY26 commentary on 'improving profitability' and 'signs of recovery' internationally, particularly the US. India, the segment management flagged as the primary growth driver, grew revenue only 7.4% YoY to ₹292.9 Cr with segment PBT roughly flat (₹23.24 Cr vs ₹23.45 Cr) — domestic growth undershot the 'double-digit' framing even as consolidated topline cleared it on the strength of international ops.
The stock went into the print at ₹227.1, down 2.9% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.
Management is optimistic about FY27, targeting double-digit growth driven by a strong domestic business which continues to gain market share. International operations are showing signs of recovery, particularly in the US, with improving profitability. The company anticipates a constructive phase in the global steel ind
— This quarter: beat
Against management's own FY27 guidance — double-digit growth led by a strong domestic business, with international recovery (especially the US) as a secondary tailwind — this quarter effectively inverts that script: the double-digit consolidated growth (12.9%) and PAT beat were delivered by the overseas turnaround rather than domestic strength, so it is a beat on substance but not on the stated mix. No formal analyst consensus for this quarter could be found (thin sell-side coverage typical of this market cap), so vs-street is unknown; no separate management press release was available beyond the regulatory filing. Alongside results, the board approved a 21.5% final dividend (₹2.15/share) and the AGM was held August 5; subsequent-to-quarter developments include incorporation of a wholly-owned Saudi subsidiary (July 11) and completion of the Czech subsidiary's voluntary liquidation (July 1) — portfolio-shaping moves, not in-quarter financial drivers. Separately, the proposed Marvels JV application for the Bhachau, Gujarat site was closed by the relevant government authority over location concerns, requiring a fresh application with an alternative site — a minor delay to a growth project, not a financial hit this quarter.
W1
India (domestic) segment revenue growth (+7.4% YoY this quarter) vs management's 'double-digit' domestic growth target — watch the Q2 FY27 India print.
W2
Raw material cost ratio (52.6% of revenue this quarter vs 47.1% a year ago) — watch whether this eases as management's stated operational-efficiency focus takes hold.
W3
America segment profitability trajectory (PBT ₹10.84 Cr this quarter, +79.5% YoY) — watch whether the US recovery management flagged continues into Q2.
Consolidated is primary (global ops). Standalone PAT growth (+7.1% YoY) is far softer than consolidated (+57.8% YoY) since standalone excludes the US/Europe subsidiaries driving the beat. No exceptional items in Q1 FY26 or Q1 FY27 (Q4 FY26 carried an immaterial ₹0.41 Cr one-off labour-code charge, not relevant to this YoY comparison). Figures converted from ₹ Lakhs to ₹ Crore (/100).
International Strength Masks Domestic Slowdown; Margins Stay Pinched
Consolidated profit surged 58%, but the growth is entirely international-driven. At home, revenue limped to 7% and EBITDA fell 17% — well short of the double-digit guidance being carried forward.
The headline looked good: consolidated revenue ₹515 Cr (+12.9% YoY), PAT ₹17 Cr (+57.8% YoY). But pull back one layer and the picture fragments. Of the ₹17 Cr PAT, nearly all came from international operations — the US growing double-digit, Monocon U.K. and Sheffield ramping through turnarounds. Standalone India — the company's largest base — grew just 7% in revenue and 7% in PAT, while EBITDA fell 17% year-on-year. This is the gap between the headline and the real story.
₹515 Cr
+12.9% YoY
₹297 Cr
+7% YoY
₹17 Cr
+57.8% YoY
₹16 Cr (approx)
+7% YoY
7.7%
vs ~9% prior
₹31 Cr
–17% YoY
Where the profit came from — and why margins compressed
Consolidated profit grew 58%, but isolation matters. The US operations delivered double-digit revenue growth with positive margins — a bright spot. Monocon U.K. and Sheffield, both in recovery mode, combined for double-digit growth despite still being loss-making or near-breakeven as entities. Together, these international operations carried the PAT story. Domestically, though, the physics worked against the company. Standalone India's gross margin fell 400 basis points — from 47% to 43% — due to sharp spikes in raw material costs (geopolitical supply chain disruptions) and LPG. Management implemented price increases across the customer base, but the lag was significant: Q1 price actions were not enough to offset the input cost shock. The result: standalone EBITDA dropped 17% YoY despite attempting to pass through costs. This is the margin pinch.
Export revenue (₹35 Cr) did better, growing 9% YoY vs. domestic's 7%. This suggests the company has product-market fit internationally where it's scaling, but domestic demand may be softening or share may be eroding — the CFO acknowledged 'almost touched double digit' on the domestic target, a candid miss.
Management claims vs. what the numbers actually show
Consolidated growth of 13%, all quarters growing
Consolidated revenue ₹515 Cr (+12.9% YoY confirmed). But standalone India only +7%, not the double-digit target.
Supported (headline), overstated (domestic)
PAT growth 58%; resilience of international operations
PAT ₹17 Cr (+57.8% YoY). Entirely driven by consolidated (international). Standalone PAT only +7%.
Supported, but international-only
Strong domestic business gaining market share
Domestic revenue +7% YoY. Export +9%. CFO said 'almost touched double digit' but fell short.
Overstated
EBITDA margin compression due to cost inflation, not competitive pricing
Standalone EBITDA down 17% YoY; gross margin fell 47% → 43% (400 bps). Raw material + LPG spikes confirmed. Price increases implemented but time lag acknowledged.
Supported
Worst is behind us; steady EBITDA margins ahead
Management concluded 'worst is behind us' but with heavy caveat: 'tomorrow brings another day, world changes fast, difficult to predict.'
Partial (cautious phrasing)
What changed on this call
Five key shifts from prior guidance:
Domestic growth softened from 'strong gains' to 7% — target miss
EBITDA margin compression expanded: standalone fell 17% YoY
International momentum confirmed: US double-digit, Monocon/Sheffield double-digit combined
Monocon losses narrowing Q-o-Q; on track to breakeven by FY27 end
Guidance reaffirmed, not raised: double-digit EBITDA margin and domestic growth targets carried forward despite Q1 miss
The bull-bear ledger
International diversification maturing: US strong, Monocon/Sheffield ramping
Price increases being implemented; CFO confident phased realization Q2–Q3 FY27
New high-margin products (tundish SEN for U.S. steel market) gaining traction
Capex roadmap: mag carbon brick + casting flux lines can add ₹150–200 Cr revenue at peak
Domestic growth stuck at 7%, well below double-digit target; structural miss, not cyclical
Margin compression acute: gross margin down 400 bps on standalone; Q1 price actions failed to offset costs
PAT margin razor-thin at 3.3% consolidated; no buffer for cost surprises or demand misses
International turnarounds (Monocon, Sheffield) execution-dependent; breakeven timelines aggressive
British Steel & Specialty Steel restarts (Q2, Q4) are customer-dependent; timing uncertain
Chinese JV stalled indefinitely; GoI approval pending location change request
Risks, ranked by how much they should concern a holder
Very thin PAT margin (3.3% consolidated)
HighMinimal buffer for cost surprises, demand misses, or competitive pressure. Any shock to pricing power or volume leaves earnings vulnerable.
Domestic growth stuck at 7% vs. double-digit target
HighSuggests underlying demand softness or share losses in the core market. If persists, consolidated growth will be capped by international pace alone.
Margin compression unresolved in Q1 despite price actions
HighRaw material and fuel costs remain volatile (geopolitical disruptions ongoing). Pricing lag of 1–2 quarters is a headwind; if cost inflation accelerates further, margin recovery delays.
British Steel & Specialty Steel customer restarts (timing & execution)
MediumSheffield & Monocon U.K. are dependent on these customers for revenue and margin recovery. Blast furnace restart (Q2) and Liberty Aldwarke melt shops restart (Q4) are not guaranteed; any delay pushes turnaround timelines.
International turnaround execution (Monocon, Sheffield, Hofmann)
MediumAll three are still loss-making or near-breakeven. Breakeven targets (FY27 end) are aggressive. Management is capable but timelines are tight, and external factors (customer demand, supply chain) are unpredictable.
Geopolitical & supply chain volatility persists
MediumRaw material scarcity and ocean freight spikes are driving margin compression. If tensions remain elevated, pricing power stays limited (temporary, not permanent increases).
Chinese JV indefinitely delayed
LowCapex timing unknown; no alternative cement-substitution path articulated. Low impact to near-term earnings, but a strategic option lost for now.
How the street is positioned
The stock is trading at ₹219 (as of 2026-08-17), above its SMA20 (₹211.17), SMA50 (₹206.23), and SMA200 (₹192.81) — a technical uptrend. It has rallied 83% from its 52-week low of ₹119.68 but sits 15.66% below its all-time high of ₹259.65, suggesting investors are still digesting near-term headwinds despite longer-term optimism. The price reaction to the Q1 result tells a story: the stock fell 0.78% on day 1 (delivery 67.3%), dropped 6.63% by day 3, and remained down 0.79% by day 5. That sustained 3-day decline of 6.63% suggests the market saw through the headline profit growth to the underlying domestic weakness and margin compression — a market verdict aligned with the fundamental read. FII ownership is minimal (0.03%) and flat sequentially; DII holding steady at 13.01%; promoter stable at 72.43%. The lack of FII accumulation despite international growth momentum is notable — it suggests large institutions are cautious, waiting for domestic stabilization or margin recovery proof before re-engaging.
What to watch next
1 · Q2 pricing realization and margin flow-through
Management expects price increases to phase in Q2–Q3. If gross margin re-expands even to 46% (halfway back to prior 47%), it validates the lag thesis. If it stays at 43% or falls further, pricing power has weakened or costs accelerated further.
2 · British Steel & Specialty Steel customer restarts
British Steel blast furnace restart expected Q2 FY27; Liberty Aldwarke (Specialty Steel) melt shops restart targeted Nov–Dec 2026 (Q3–Q4 FY27). These are make-or-break for Sheffield and Monocon U.K. margin recovery. Any delay pushes turnaround timelines backward.
3 · Domestic growth re-acceleration
Can management reignite domestic revenue to double-digit by Q2–Q4? If it stays at 7%, it signals a structural miss and undermines the 'market share gains' narrative. This is the validation check for management credibility.
IFGL is executing a difficult playbook: managing mature domestic operations (7% growth, margin-pressured) while nursing international turnarounds (US strong, Europe ramping). The headline numbers (revenue +13%, PAT +58%) gloss over a hollowed-out domestic core and razor-thin margins. Guidance was reaffirmed, not raised — management's own signal that Q1 was not a proof point for acceleration. The market's negative price reaction (down 6.63% by day 3) was justified: the stock rallied on international optimism, but the Q1 print raised real doubts about execution.
The pivot for holders is Q2–Q3. If pricing flows through (gross margin re-expands) and customer restarts execute (Sheffield, Monocon U.K. turn cash-positive), the turnaround thesis holds and the stock has upside. If margins stay pinched or domestic slips further, the consolidated growth story unravels. Until then, this is a Hold — wait for proof. The number to track: standalone India EBITDA margin. If it returns to 10%+ by Q3 FY27, the company has won. If it stays at 8–9%, the structural headwinds are real, and the multiple likely compresses further.
Margin pinch amid solid international; domestic slipping
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
No formal prior numeric guidance breached; aspirational targets (double-digit margins, domestic growth) carried forward but Q1 delivery below aspirations. Monocon losses narrowing as promised.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Consolidated delivery in line with reported numbers, but margins compressed (7.7% EBITDA, 3% PAT) and domestic growth (7% standalone) well below double-digit target. Offset by strong US performance and Monocon/Sheffield turnarounds progressing. Pricing should flow through Q2–Q3; monitor if domestic recovers.
₹512.4 Cr
Revenue · +12.9% YoY₹17.1 Cr
Reported PAT · +57.8% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Consolidated growth of 13% YoY; all quarters growing
METConsolidated revenue ₹515 Cr vs prior ~₹455 Cr; 13% growth confirmed. But standalone India only 8%.
PAT growth 58% YoY; resilience of international operations
METPAT ₹17 Cr vs prior ~₹10.8 Cr = 57.8% growth. Entirely driven by consolidated (US + UK + Germany). Standalone PAT only 7%.
Domestic momentum, market share gains, growing ahead of market
OVERSTATEDDomestic standalone only 7% growth; export 9%. Consolidated 13% includes international. CFO acknowledged 'almost touched double digit' but fell short.
EBITDA margin compression due to cost inflation and supply chain, not competitive pricing
METStandalone EBITDA down 17% YoY; gross margin fell from 47% to 43% (400 bps). Raw material + LPG cost spikes confirmed. Price increases implemented but time lag acknowledged.
Worst is behind us; expecting steady EBITDA margins ahead
PartialManagement concluded 'worst is behind us' but with heavy caveat: 'tomorrow brings another day, world changes fast, difficult to predict.' Cautious phrasing.
Earnings quality
What changed since the last call
Domestic momentum softens
DowngradePrior call: strong domestic gains. Q1: standalone 8% vs 7.4% market forecast. CFO 'almost touched double digit' – miss vs target.
EBITDA margin compression expands
DowngradeStandalone EBITDA down 17% YoY; gross margin fell 400 bps (47% → 43%). Raw material + LPG spike worse than expected. Pricing lag unresolved.
International momentum confirmed
UpgradeUS double-digit growth; Monocon/Sheffield double-digit combined. UK sentiment improved (British Steel public ownership de-risks longevity).
Monocon losses narrowing
UpgradePrior: Monocon under pressure. Q1: losses shrunk Q-o-Q (no exact number divulged but CFO confirmed narrowing). On track to breakeven by FY27 end.
Guidance maintained, not raised
NeutralPrior: 'double-digit growth', 'strong domestic', 'international recovery'. Q1: same aspirations reaffirmed but domestic (7%) and EBITDA (7.7%) fell short. No numeric upward revision.
The Q&A
Analysts pressed on domestic slowdown (7% vs target), EBITDA compression, and Monocon losses. Management defended via cost inflation + pricing lag, held firm on international strength (US). Some deflection on R&D capex spend and Monocon loss quantum (not divulged). Tone: realistic but mildly defensive.
International business drivers — Krishna, Prathamesh Invest
PartialAmericas driving growth with robust margins. Individual company details withheld; segment results published separately. Momentum expected to maintain across U.K., Europe, Americas, Germany; focus on profitability turnarounds.
Sheffield tech transfer — Snehal Surana, Star Broking
AnsweredPhase 1 ramming mass now in production at Vizag facility; marketing trials ongoing. Other products in joint visits and trials with customers; will take time for full market maturation and accreditation.
Domestic growth & margin compression — Amit Ahuja, CJ Capital
PartialBase effect (prior year smaller base). Consol approach shows better—export strong. EBITDA dip due to raw material and LPG cost spike, not competitive pricing. Price increases implemented; insufficient to offset in Q1.
Europe EBITDA volatility — Sahil Sanghvi, Monarch Networth Capital
AnsweredEurope = Monocon U.K. + Sheffield. Both individually good. Sheffield suffered due to British Steel blast furnace shutdown (timing, not structural loss). Monocon U.K. moving to breakeven. Q2 expected normal when British Steel restarts.
Price increase realization — Sahil Sanghvi, Monarch Networth Capital
AnsweredPrice increases on contract-by-contract basis, not evenly distributed. Temporary increases tied to input cost shocks (geopolitical). No additional margin uplift expected; aim to compensate only.
Long-term EBITDA margin target — Sahil Sanghvi, Monarch Networth Capital
PartialTargeting double-digit EBITDA margin (consol). Dependent on geopolitical and overseas demand. Will be back on this.
Liberty Steel historical dues recovery — Sahil Sanghvi, Monarch Networth Capital
AnsweredUnlikely. Old dues unsecured; administrators will handle post-new-buyer. Upside: can resell products and re-establish service team if restart succeeds.
Monocon geographic expansion — Sahil Sanghvi, Monarch Networth Capital
AnsweredIron/steel refractory products; foundry industry entry planned. Geographies: U.K., China; recently opened Australia and Saudi Arabia offices. Strong customer feedback from Mexico and U.S.A. for market expansion.
EBITDA margin improvement drivers — Saket Kapoor, Kapoor & Company
PartialMonocon U.K. back to black will lift overall EBITDA. U.S. already double-digit margin contributor. Each subsidiary being worked to restore past margins.
Monocon loss quantum — Saket Kapoor, Kapoor & Company
DodgedNot divulging exact loss number. But losses narrowed Q-o-Q for Monocon U.K.
R&D facility capex — Saket Kapoor, Kapoor & Company
PartialCorrection: R&D spend ~₹20 Cr. Facility developing new materials (foundry); special tundish SEN for thin slab caster (U.S. market, showing strong results); recycling initiatives; team augmentation. R&D supporting global sales.
Chinese JV status — Saket Kapoor, Kapoor & Company
AnsweredJV applied to Government of India; advised to change location and reapply. Awaiting approval. On hold. Gujarat land acquisition done; some marketing spend. Cement industry import substitution focus.
Peak capacity revenue potential — Sanchita Sood, RoboCapital
PartialNo specific current capacity number. Mag carbon brick + casting flux new lines can add ₹150–200 Cr at peak capacity for those two products alone.
Guidance
Double-digit domestic growth target by year-end FY27
MediumAspiration carried forward; Q1 only 7%. CFO said 'almost touched double digit'. Requires Q2–Q4 acceleration to +12% or higher.
Overseas momentum to be maintained across subsidiaries
HighU.S. strong; Monocon U.K. and Sheffield on recovery path; geographic expansion (Saudi, Australia) beginning.
Capex-driven capacity upside: ₹150–200 Cr from mag carbon brick + casting flux at peak
MediumNew lines not yet at peak; timeline not specified. Provisional upside target.
Double-digit consolidated EBITDA margin aspiration
MediumCurrent: 7.7% (Q1 FY27). Prior target cited; not formally changed. Dependent on Monocon U.K. breakeven and cost absorption.
Price increases to continue; benefit phased in Q2–Q3 FY27
MediumNo margin uplift in Q1 due to lag. CFO: 'temporary price increases based on input costs; no additional margin expected; aim to compensate only.'
Mag carbon brick and casting flux new lines: ₹150–200 Cr revenue at peak capacity
MediumIncremental capex spend not quantified. Timeline for these new lines not specified on call.
Chinese JV on hold; awaiting Government of India location approval
LowCapex timing indefinite. Land acquisition in Gujarat already done (spend undisclosed).
R&D facility in Odisha: supporting innovation (tundish SEN, material recycling, foundry entry)
HighR&D spend ~₹20 Cr; facility works ongoing. Delivering tangible wins (U.S. tundish market, foundry entry for Monocon).
Risks the call surfaced
Margin compression
HighRaw material (geopolitical + supply chain) and LPG costs up sharply. Standalone EBITDA down 17% YoY despite price increases. Pricing actions take 1–2 quarters to flow through.
Domestic demand softness
MediumStandalone domestic revenue only +7% YoY (target: double-digit). CFO acknowledged 'almost touched double digit' but fell short. Market share claims not directly supported by growth rate.
International turnaround execution risk
MediumMonocon U.K. and Sheffield ramping but losses still material. Hofmann Ceramic targeting breakeven by FY27 end (aggressive). Exposure to British Steel timing and other customer volatility.
British Steel & Europe cycle risk
HighSheffield revenue collapsed Q1 due to British Steel blast furnace outage (timing, not structural). Restart expected Q2 but timing uncertain. Liberty Steel (Specialty Steel) restart Nov–Dec 2026 not guaranteed.
Geopolitical & supply chain disruptions
MediumGeopolitical uncertainties driving raw material cost spikes. Ocean freight surge (UK, China operations impacted). Supply chain disruptions ongoing.
Chinese JV uncertainty
LowChinese JV (cement industry import substitution) on hold awaiting GoI approval after location change request. Land acquisition in Gujarat done; timing unknown.
Management
Score 6/10. Transparent on cost headwinds and margin compression; acknowledged pricing lag. Some defensiveness on domestic slowdown (base effect explanation). Withheld Monocon loss specifics and R&D capex detail. Mixed. U.S. operations strong and on track. Monocon/Sheffield turnarounds in progress (losses narrowing). Domestic growth (7%) missing double-digit target. Prior aspirational targets not yet materialized in Q1.
1 · Q2 FY27
Pricing actions flow through; British Steel blast furnace restart lifts Sheffield sales
2 · Q3–Q4 FY27
Specialty Steel (Liberty Aldwarke) melt shops restart in Nov–Dec; Monocon UK breakeven reached
3 · FY28
Mag carbon brick and casting flux lines reach peak capacity; Sheffield integration matures
Pricing should flow through Q2–Q3; monitor if domestic recovers.